Measuring Subjective Quality of Vision and Metamorphopsia Before and After Epiretinal Membrane and Macular Hole Surgery

Epiretinal Membrane Clinical Trial

— MQUEST  

Official title:

Measuring Subjective Quality of Vision and Metamorphopsia Before and After Epiretinal Membrane and Macular Hole Surgery

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05171621
• Other study ID #: 18/NOV/7557
• Status: Completed
• Start date: October 16, 2019
• Est. completion date: October 31, 2021

Study information

• Verified date: December 2021
• Source: University Hospital of Wales
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Assessing metamorphopsia and quality of vision pre and post epiretinal and macular hole surgery

Description:

Metamorphopsia is a visual symptom in which straight lines appear distorted, for example a vertical window blind may appear wavy which can affect quality of vision. Metamorphopsia is a common symptom in retinal conditions such as epiretinal membranes (ERM) and macular holes. There is a lack of studies analysing the prevalence of ERM in the UK and Europe. Both of the conditions have shown to be a higher risk factor with age. With an aging population it is likely these numbers will increase. Currently the only treatment option is surgery (vitrectomy) or conservative management to monitor the condition. It would therefore be beneficial to find a tool that would inform the surgeon of a patient's quality of vision and how this impacts their life. A patient's severity of metamorphopsia reveals more precise information on the progression of the disease than visual acuity alone (Nomoto et al. 2013) therefore gaining a better understanding can help aid clinical decisions. Current clinical practice is to monitor metamorphopsia with an Amsler chart, a grid with lines; the patient is then asked to draw where they can see distortion. They are used to detect metamorphopsia but are unable to quantify and provide an accurate measurement of the severity of metamorphopsia and quality of vision The Quality of Vision questionnaire (QoV) (McAlinden et al. 2010) is a modern tool developed to specifically measure subjective quality of vision. The Metamorphopsia questionnaire (Arimura et al. 2011) has been developed to provide a measurement of subjective metamorphopsia in macular disease. Both have been psychometrically validated and are in use in a number of clinical trials worldwide. It would be valuable to investigate the role of each questionnaire in identifying quality of vison and metamorphopsia pre- and post-surgery for ERM and macular holes to establish if there are changes to patient responses. We would compare this to visual acuity and optical coherence tomography (OCT) images pre- and post-surgery to see if changes correspond to the questionnaire responses. If a questionnaire can measure metamorphopsia and its impact on quality of vision in ERM and macular holes, this would assist in clinical decision making.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 50
• Est. completion date: October 31, 2021
• Est. primary completion date: October 31, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Participant is willing and able to give informed consent
• >18 years old
• Patients listed for epi retinal and macular hole surgery
• Patient is able to perform study procedures

Exclusion Criteria:

• Patients who are diagnosed with a condition other than epiretinal membrane or macular hole
• Patients not undergoing epiretinal or macular hole surgery
• Patients will be excluded if there are any complications within surgery, or undergo any procedures that is not an epiretinal or macular hole surgery (i.e vitrectomy, phacoemulsification (lens extraction) as this can affect visual outcomes.

Related Conditions & MeSH terms

• Epiretinal Membrane
• Macular Holes
• Metamorphopsia
• Ophthalmologic Complication
• Retinal Perforations
• Vision Disorders

Locations

Country	Name	City	State
United Kingdom	University Hospital of Wales	Cardiff

Sponsors (1)

Lead Sponsor	Collaborator
Hayley Westwood

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Assess correlations between the Mcallinden and Metamorphopsia questionnaire scores and objective clinical parameters	do the questionnaires show changes pre and post surgery and do they match clinical outcomes	Pre surgery and 2-3 month post surgery
Primary	Compare the responses of the McAllinden and Metamorphopsia Questionnaire	analysing changes to responses in the 2 questionnaires pre and post surgery	pre surgery and 2 - 3 months post surgery
Secondary	Changes to BCVA score	Patients BCVA pre and post surgery to see if there is an improvement	Pre surgery and 2-3 months post surgery